Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

33.47B

Market cap33.47B

Price-Earnings ratio

13.49

Price-Earnings ratio13.49

Dividend yield

2.55%

Dividend yield2.55%

Average volume

3.97M

Average volume3.97M

High today

$81.86

High today$81.86

Low today

$80.00

Low today$80.00

Open price

$81.62

Open price$81.62

Volume

2.86M

Volume2.86M

52 Week high

$147.93

52 Week high$147.93

52 Week low

$68.77

52 Week low$68.77

Stock Snapshot

With a market cap of 33.47B, Zoetis(ZTS) trades at $80.00. The stock has a price-to-earnings ratio of 13.49 and currently yields dividends of 2.55%.

During the trading session on 2026-10-23, Zoetis(ZTS) shares reached a daily high of $81.86 and a low of $80.00. At a current price of $80.00, the stock is 0.0% higher than the low and still -2.3% under the high.

Trading volume for Zoetis(ZTS) stock has reached 2.86M, versus its average volume of 3.97M.

The stock's 52-week range extends from a low of $68.77 to a high of $147.93.

ZTS News

Zacks 2h

Zoetis Registers a Bigger Fall Than the Market: Important Facts to Note

In the latest close session, Zoetis (ZTS Quick QuoteZTS - Free Report) was down 1.18% at $81.03. The stock trailed the S&P 500, which registered a daily l...

Zacks 2d

ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?

Zoetis Inc. (ZTS Quick QuoteZTS - Free Report) and ImmuCell Corporation (ICCC Quick QuoteICCC - Free Report) operate in the animal health industry b...

Investing.com 3d

FDA approves Zoetis’ Convenia RTU for canine skin infections - Investing.com

...

Analyst ratings

72%

of 18 ratings

Buy

27.8%

Hold

72.2%

Sell

More ZTS News

TipRanks 3d

Zoetis announces FDA approval of Convenia RTU for Dogs

Zoetis (ZTS) announced that the U.S. FDA has approved Convenia RTU for Dogs for the treatment of susceptible bacterial skin infections in dogs. For many familie...

TipRanks 4d

Zoetis downgraded to Hold from Buy at Jefferies

Jefferies analyst Keith Devas downgraded Zoetis (ZTS) to Hold from Buy with a price target of $83, down from $103. The firm cites the company’s softer pricing e...

Simply Wall St 5d

Zoetis Could Be 15% Undervalued Following Its 2026 Earnings Outlook Cut

Advertisement Board appointment and earnings reset put Zoetis in focus Zoetis (ZTS) is back on investor radars after management cut its 2026 earnings outlook...

Simply Wall St 6d

Will Lower Earnings Outlook Change Zoetis Stock Narrative

Zoetis cut its 2026 earnings outlook after reporting softer demand in its U.S. companion-animal business, while livestock and international operations provided...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.